🇪🇸 100% SPAIN STOCK·FAST 24-72H DISPATCH

HOME/CATALOG/Metabolic Peptides.
METABOLIC PHARMACOLOGY & INCRETIN AGONISM

Metabolic Peptides.

Bioactive compounds targeting GLP-1, GIP, GCGR receptors and cellular bioenergetics.

Incretin receptor agonist research represents the benchmark in modern metabolic biology. These vacuum-lyophilized research compounds allow investigation into hypothalamic satiety pathways, adipose thermogenesis, and intracellular enzyme modulation (NNMT) in preclinical models.

≥99%HPLC Verificado
24-72HEntrega España
0% ADUANASEnvíos Intra-UE

AVAILABLE RESEARCH COMPOUNDS

4 Compounds
retatrutide
RET-05032620 mg
Metabolic
≥99% HPLC

retatrutide

triply activates the gipr, glp-1r, and gcgr pathways, resulting in drastic body weight reduction, glucose control, and elimination of accumulated liver fat.

FROM€69.95/ 20 mg
VIEW
tirzepatide
TIR-04122610 mg
Metabolic
≥99% HPLC

tirzepatide

simultaneously activates gip and glp-1 receptors in a biased manner, resulting in massive weight loss, superior metabolic control, and prolonged suppression of food cravings.

FROM€39.95/ 10 mg
VIEW
semaglutide
SEM-05232610 mg
Metabolic
≥ 99.0%

semaglutide

selective glp-1 receptor agonist that optimizes glycemic regulation and incretin-driven metabolic satiety in research models.

PRICE€34.95/ 10 mg
VIEW
5-amino-1mq
5-A-05242610 mg
Longevity
≥99% HPLC
OUT OF STOCK

5-amino-1mq

blocks the nnmt enzyme to reverse cellular fat accumulation, resulting in optimized weight loss, accelerated energy metabolism, and enhanced body fat burning.

PRICE€49.95/ 10 mg
VIEW

PRECLINICAL PHARMACOLOGICAL ANALYSIS

Molecular Mechanisms of Action

Metabolic peptide analogs operate via targeted activation of G-protein coupled receptors (GPCRs). Dual-agonists such as Tirzepatide recruit GIPR and GLP-1R pathways to enhance glucose homeostasis, while tri-agonists like Retatrutide incorporate glucagon receptor (GCGR) affinity, driving hepatic lipid beta-oxidation and basal metabolic expenditure in laboratory protocols.

Nanomolar binding affinity (EC50) across recombinant human target receptors.
High-density lyophilization with guaranteed 102% minimum fill volume.
Selective intracellular NNMT enzyme inhibition via 5-Amino-1MQ assays.
Batch-verified HPLC and Mass Spectrometry (MS) purity >99.0%.

FREQUENTLY ASKED QUESTIONS

What is the distinction between a dual agonist (Tirzepatide) and a triple agonist (Retatrutide)?

Tirzepatide activates GLP-1 and GIP receptors. Retatrutide recruits a third receptor: GCGR (glucagon), accelerating hepatic lipid clearance and elevating basal energy expenditure in comparative literature.

How should research lyophilized peptides be stored?

Dry lyophilized powder should be stored protected from light at -20°C to 4°C. Once reconstituted with bacteriostatic water, storage at 2°C to 8°C is strictly required.